CST3 and hypertensive nephropathy: In this study, we conducted a meta-analysis based on 20 RCTs to determine the efficacy of alprostadil in patients with hypertensive nephropathy by using six indicators of hypertensive nephropathy: 24-hour urinary protein, SCr, Ccr, BUN, cystatin C and MAP.